Featured Research

from universities, journals, and other organizations

New challenges for ex-Olympians

Date:
September 21, 2012
Source:
University of Gothenburg
Summary:
When elite-level athletes retire, they often struggle to adapt to their new lives. When finding that the characteristics that were valuable in sport are not equally useful in ‘ordinary’ life, they often start experiencing disorientation, depression, self-doubt or even illness.

When elite-level athletes retire, they often struggle to adapt to their new lives. When finding that the characteristics that were valuable in sport are not equally useful in 'ordinary' life, they often start experiencing disorientation, depression, self-doubt or even illness. This is concluded in research from the University of Gothenburg.

Successful athletes at the elite level develop characteristics that should generate success also later in life. However, this notion may be wrong, according to the new research.

As part of a study, ex-Olympians from Sweden, Switzerland, USA and Australia were interviewed. All subjects participated in either the 2008 Summer Olympics in Beijing or the 2010 Winter Olympics in Vancouver.

Some well-developed features turned out to be very useful in the retired atheltes' lives. Two examples are perseverance and organisational skills.

However, characteristics, such as perfectionism, hyper-competitiveness, self-centredness and submissiveness, are much less useful and are indeed not desired -- at work, in school and in family life.

'Some ex-athletes say that adapting to post-sport life is more difficult than anything they ever experienced as athletes,' says Natalie Barker at the University of Gothenburg, who headed the research project.

The study reveals that those who managed to keep some kind of distance to their sport, or who were able to critically reflect on their experiences, were able to develop a more flexible and mature self-image.

The study was carried out jointly by researchers at the University of Gothenburg and two Australian universities.


Story Source:

The above story is based on materials provided by University of Gothenburg. The original article was written by Torsten Arpi. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "New challenges for ex-Olympians." ScienceDaily. ScienceDaily, 21 September 2012. <www.sciencedaily.com/releases/2012/09/120921083200.htm>.
University of Gothenburg. (2012, September 21). New challenges for ex-Olympians. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2012/09/120921083200.htm
University of Gothenburg. "New challenges for ex-Olympians." ScienceDaily. www.sciencedaily.com/releases/2012/09/120921083200.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins